Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bipolar Disorder With Manic or Mixed Episodes”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Large-scale testing (Phase 3)Study completedNCT00035230
What this trial is testing

A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 338
Post-approval studies (Phase 4)Study completedNCT00190892
What this trial is testing

Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania

Who this might be right for
Bipolar Disorder
Eli Lilly and Company 120
Large-scale testing (Phase 3)Ended earlyNCT01122927
What this trial is testing

Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.

Who this might be right for
Adolescent SchizophreniaChild or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Otsuka Pharmaceutical Development & Commercialization, Inc. 524
Large-scale testing (Phase 3)Study completedNCT03573297
What this trial is testing

A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features

Who this might be right for
Bipolar I DisorderManiaDepression
AbbVie 901
Large-scale testing (Phase 3)Study completedNCT00102518
What this trial is testing

Aripiprazole Open-Label, Safety and Tolerability Study

Who this might be right for
SchizophreniaBipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 325
Large-scale testing (Phase 3)Study completedNCT01349907
What this trial is testing

Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898)

Who this might be right for
Bipolar Disorder
Organon and Co 322
Large-scale testing (Phase 3)Study completedNCT00606177
What this trial is testing

A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 99
Post-approval studies (Phase 4)Study completedNCT00191997
What this trial is testing

Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode

Who this might be right for
Bipolar Disorder
Eli Lilly and Company 180
Large-scale testing (Phase 3)Study completedNCT00764478
What this trial is testing

Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691)

Who this might be right for
Bipolar 1 Disorder
Organon and Co 367
Large-scale testing (Phase 3)Study completedNCT03259555
What this trial is testing

A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder

Who this might be right for
Bipolar I DisorderManic Episode
Otsuka Pharmaceutical Development & Commercialization, Inc. 322
Large-scale testing (Phase 3)Study completedNCT01602510
What this trial is testing

Lamotrigine Phase III Study in Bipolar I Disorder

Who this might be right for
Bipolar Disorder
GlaxoSmithKline 265
Large-scale testing (Phase 3)Study completedNCT00309686
What this trial is testing

Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder

Who this might be right for
Affective Psychosis, BipolarBipolar DisorderMania
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 300
Not applicableStudy completedNCT00454883
What this trial is testing

Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.

Who this might be right for
Affective Psychosis, BipolarManiaManic-Depressive Psychosis
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 379
Large-scale testing (Phase 3)Study completedNCT00266630
What this trial is testing

Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder

Who this might be right for
Manic or Mixed Episode Associated With Bipolar I Disorder
Eli Lilly and Company 139
Large-scale testing (Phase 3)Study completedNCT00249236
What this trial is testing

The Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Who this might be right for
Bipolar DisorderManic Episode
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 291
Post-approval studies (Phase 4)Study completedNCT00397020
What this trial is testing

Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapine for Adults With Acute Mania or Mixed Episodes

Who this might be right for
Bipolar Disorder
University of California, San Diego 30
Large-scale testing (Phase 3)Study completedNCT00037674
What this trial is testing

A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 434
Post-approval studies (Phase 4)Study completedNCT00982020
What this trial is testing

Study in Adolescents With Schizophrenia or Bipolar Disorder

Who this might be right for
Bipolar I DisorderSchizophrenia
Eli Lilly and Company 203
Testing effectiveness (Phase 2)Study completedNCT00374920
What this trial is testing

Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder

Who this might be right for
Bipolar Disorder With Manic or Mixed Episodes
Memory Pharmaceuticals 60
Large-scale testing (Phase 3)Study completedNCT00240721
What this trial is testing

The Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder

Who this might be right for
Bipolar DisordersMood DisordersAffective Disorders, Psychotic
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 363
Load More Results